You have no items in your shopping cart.
You have no items in your shopping cart.
Catalog Number | orb1941727 |
---|---|
Category | Small Molecules |
Description | Anti-MI/R injury agent 1 (compound 18), derived from Panaxatriol, is an orally administered, potent agent against myocardial ischemia/reperfusion (MI/R) injury. It improves cell viability in cardiomyocytes subjected to oxygen-glucose deprivation and reperfusion (OGD/R)-induced injury, significantly reduces myocardial infarction size, diminishes levels of circulating cardiac troponin I (cTnI), and mitigates cardiac tissue damage in rat models [1]. |
Purity | 98.00% |
MW | 543.73 |
Biological Activity | Anti-MI/R injury agent 1 (compound 18), derived from Panaxatriol, represents an orally administered, potent agent against myocardial ischemia/reperfusion (MI/R) injury. It improves cell viability in cardiomyocytes subjected to oxygen-glucose deprivation and reperfusion (OGD/R)-induced injury. Furthermore, this compound significantly reduces myocardial infarction size, diminishes levels of circulating cardiac troponin I (cTnI), and mitigates cardiac tissue damage in rat models [1]. |
CAS Number | 2387506-35-4 |
Formula | C32H49NO6 |
SMILES | C[C@@]12[C@@]3([C@](C)([C@@]4(C)[C@]([C@H](O)C3)([C@](CC4)([C@]5(C)OC(C)(C)CCC5)[H])[H])C[C@H](O)[C@]1(C(C)(C)C6=C(C2)C(C(O)=O)=NO6)[H])[H] |
Storage | -20°C |
Note | For research use only |